⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11014798 | 1.00 | — | — | |
| SCHEMBL292798 | 1.00 | — | — | |
| SCHEMBL88667 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL489347 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL5763760 | 0.97 | — | — | |
| Ammonia Solution, Strong SCHEMBL28535747 | 0.97 | — | — | |
| Ammonia Solution, Strong SCHEMBL28466062 | 0.97 | — | — | |
| Ammonia Solution, Strong SCHEMBL1561055 | 0.97 | — | — | |
| SCHEMBL2442076 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL21808011 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6156752-A | Optically active 1,4-dihydropyridine compounds as bradykinin antagonists | PFIZER INC (US) | 2000-12-05 | — | — | US | claimed |
| EP-0899261-A1 | Optical active 1,4-dihydropyridine compounds as bradykinin antagonists | PFIZER INC. (US) | 1999-03-03 | — | — | EP | claimed |
| EP-0252720-B1 | PRISTINAMYCIN PROCESS | MAY & BAKER LIMITED (GB) | 1991-09-18 | — | — | EP | claimed |
| US-4866172-A | Pristinamycin process | MAY & BAKER LIMITED (GB) | 1989-09-12 | — | — | US | claimed |
| EP-0252720-A2 | Pristinamycin process | MAY & BAKER LIMITED (GB) | 1988-01-13 | — | — | EP | claimed |
| WO-2024148274-A1 | COMPLEMENT INHIBITION | APELLIS PHARMACEUTICALS, INC. (US) | 2024-07-11 | — | — | WO | disclosed |
| WO-2024138206-A1 | FLUOROPYRIDOPYRIMIDINE AND FLUOROQUINAZOLINE DERIVATIES AND METHODS OF USE THEREOF | FRONTIER MEDICINES CORPORATION (US) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024124002-A1 | COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS | THIRD HARMONIC BIO, INC. (US) | 2024-06-13 | — | — | WO | disclosed |
| US-20240074300-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-02-29 | — | — | US | disclosed |
| WO-2024036254-A2 | SYNTHETIC PROCESSES AND INTERMEDIATES FOR PREPARING THERAPEUTIC AZAKETOLIDES | ZIKANI THERAPEUTICS, INC. (US) | 2024-02-15 | — | — | WO | disclosed |
| WO-2024015251-A1 | INHIBITORS OF HPK1 AND METHODS OF USE THEREOF | ARCUS BIOSCIENCES, INC. (US) | 2024-01-18 | — | — | WO | disclosed |
| WO-2024009191-A1 | PYRIDO[4,3-D]PYRIMIDINE COMPOUNDS | PFIZER INC. (US) | 2024-01-11 | — | — | WO | disclosed |
| EP-1070065-A1 | AZABICYCLIC 5HT1 RECEPTOR LIGANDS | Pfizer Products Inc. (US) | 2001-01-24 | — | — | EP | disclosed |
| US-6156752-A | Optically active 1,4-dihydropyridine compounds as bradykinin antagonists | PFIZER INC (US) | 2000-12-05 | — | — | US | disclosed |
| WO-1999052907-A1 | AZABICYCLIC 5HT1 RECEPTOR LIGANDS | PFIZER PRODUCTS INC. (US) | 1999-10-21 | — | — | WO | disclosed |
| EP-0899261-A1 | Optical active 1,4-dihydropyridine compounds as bradykinin antagonists | PFIZER INC. (US) | 1999-03-03 | — | — | EP | disclosed |
| EP-0252720-B1 | PRISTINAMYCIN PROCESS | MAY & BAKER LIMITED (GB) | 1991-09-18 | — | — | EP | disclosed |
| US-4866172-A | Pristinamycin process | MAY & BAKER LIMITED (GB) | 1989-09-12 | — | — | US | disclosed |
| EP-0252720-A2 | Pristinamycin process | MAY & BAKER LIMITED (GB) | 1988-01-13 | — | — | EP | disclosed |
| EP-0252720-A2 | Pristinamycin process | MAY & BAKER LIMITED (GB) | 1988-01-13 | — | — | EP | disclosed |